Problem statement: Answer the multiple-choice question.
Question: Which compound exhibits a -12.011\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any other words.
Options:
a CCc1ccc(N2C(=O)c3sc4nnc(C)c(=O)n4c3C2=O)cc1
b CN(CCNC(=O)C1CC(=O)N(C2CCCC2)C1)Cc1ccccc1
c Cc1cc(N(CN2CCCC2=O)C(=O)c2ccccc2)no1
d CN(C)S(=O)(=O)c1cccc(NC(=S)N/N=C/C(=O)c2ccccc2)c1
Answer: a. CCc1ccc(N2C(=O)c3sc4nnc(C)c(=O)n4c3C2=O)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
4-(4-ethylphenyl)-11-methyl-7-thia-1,4,9,10-tetrazatricyclo[6.4.0.02,6]dodeca-2(6),8,10-triene-3,5,12-trione